The hypothesis is that the combination of endometrial ablation and LNG-IUS is superior to endometrial ablation alone in terms of substantially reducing subsequent rates of hysterectomy within two year after treatment with 7%.
ID
Bron
Verkorte titel
Aandoening
Heavy menstrual bleeding
Dysmenorroea
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Hysterectomy rate after 2 years of follow-up.
Achtergrond van het onderzoek
Rationale
Heavy menstrual bleeding (HMB) is a frequent problem affecting 1 in 4 women between 30 and 50 years. Endometrial ablation (EA) is a widely used procedure to treat HMB. However, 12-25% of women are dissatisfied after EA because of persisting abnormal uterine bleeding (AUB) and/or dysmenorrhea and most of these symptomatic women ultimately undergo a hysterectomy.
Adding a levonorgestrel releasing intrauterine system (LNG-IUS) inactivates the residual or regenerative endometrial tissue. This will reduce the pre-existing cyclical pelvic ‘period’ pain and minimise or eradicate iatrogenic pelvic pain induced by intrauterine adhesion formation associated with endometrial ablative treatment. Although, adding a LNG-IUS is not usual care for heavy menstrual bleeding treatment.
We hypothesize that the combination of endometrial ablation and LNG-IUS is superior to endometrial ablation alone in terms of substantially reducing subsequent rates of hysterectomy and alleviating pain and heavy menstrual bleeding.
Objective
To determine whether the introduction of a LNG-IUS directly after endometrial ablation (EA) reduces the need for subsequent hysterectomy and alleviates pain and heavy menstrual bleeding compared with endometrial ablation alone.
Study design
Multicentre randomized controlled trial.
Study population
Women suffering from heavy menstrual bleeding without contraindications for use of the LNG-IUS who opt for treatment with EA.
Intervention
Endometrial ablation and LNG-IUS combined.
Usual Care / comparison
Endometrial ablation alone
Main study parameters / endpoints
Primary: hysterectomy rate after 2 years of follow-up.
Secondary: patient satisfaction, PBAC-score, quality of life, cyclic and non-cyclic pelvic pain, re-interventions, complications, side-effects and cost-effectiveness.
Doel van het onderzoek
The hypothesis is that the combination of endometrial ablation and LNG-IUS is superior to endometrial ablation alone in terms of substantially reducing subsequent rates of hysterectomy within two year after treatment with 7%.
Onderzoeksopzet
At baseline, after 6, 12, 18 en 24 months
Onderzoeksproduct en/of interventie
Endometrial ablation and LNG-IUS combined.
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Women suffering from heavy menstrual bleeding, who do not wish or benefit from another treatment for heavy menstrual bleeding (medication or LNG-IUS) and opt for treatment with EA, irrespective of the existence of fibroids, polyps or adenomyosis. Earlier use of LNG-IUS is no exclusion.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
• Women who don’t speak Dutch or English to a standard that they can fully understand the study and complete the trial questionnaires.
• Women who might want to get pregnant in the future will not be included since an endometrium ablation interferes with future pregnancies.
• Suspicion on endometrial cancer.
• Contra-indications for levonorgestrel IUD.
• Already performed Eandometrial Ablation.
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL7817 |
CCMO | NL69895.015.19 |
OMON | NL-OMON54839 |